During the past decade, Saiseikai Kumamoto Hospital conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 17 clinical trials were completed, i.e. on average, 63% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 13 clinical trials were completed. i.e. 86.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saiseikai Kumamoto Hospital" #1 sponsor was "Abbott Medical Devices" with 5 trials, followed by "Boehringer Ingelheim" with 4 trials sponsored, "Pfizer" with 4 trials sponsored, "Associations for Establishment of Evidence in Interventions" with 2 trials sponsored and "Bayer" with 2 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saiseikai Kumamoto Hospital" #1 collaborator was "Abbott" with 2 trials as a collaborator, "Medtronic" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Beijing Tiantan Hospital" with 1 trials as a collaborator and "Boehringer Ingelheim" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Saiseikai Kumamoto Hospital" are "Coronary Artery Disease" (6 trials), "Idiopathic Pulmonary Fibrosis" (4 trials), "Heart Failure" (3 trials), "Myocardial Ischemia" (3 trials) and "Arrhythmias, Cardiac" (2 trials). Many other conditions were trialed in "Saiseikai Kumamoto Hospital" in a lesser frequency.

Most popular intervention types in "Saiseikai Kumamoto Hospital" are "Drug" (22 trials), "Device" (10 trials), "Other" (4 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "BAY2433334" (2 trials), "BAY2433334 matching placebo" (2 trials), "GLPG1690" (2 trials) and "Nintedanib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Saiseikai Kumamoto Hospital" are 37 trials for "All" genders.

Currently, there are NaN active trials in "Saiseikai Kumamoto Hospital". undefined are not yet recruiting, 6 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Saiseikai Kumamoto Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Saiseikai Kumamoto Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 8 trials that are defined as “Not Applicable".